Zepbound Dosing

Zepbound helps you reduce body weight and maintain weight loss when combined with a reduced-calorie diet and increased physical activity. It’s specifically for adults with obesity or those who are overweight and have at least one weight-related condition. The dual action of these receptors makes Zepbound a powerful option for weight management, standing out from other treatments.

Clinical trials show the efficacy of Zepbound with dose-dependent reductions of 11.9 lbs at 5 mg and 23.1 lbs at 15 mg weekly. These results surpass placebo and other GLP-1 receptor agonists, making Zepbound a top recommendation by the American Diabetes Association (ADA) for weight management.

This article provides detailed information on Zepbound dosing to ensure you get the most out of your treatment.

Quick Facts on Zepbound Dosing

• • Zepbound starts at a 2.5 mg dose for the first 4 weeks, helping the body adjust gradually to the medication and minimize potential side effects like nausea or diarrhea.

• • Even the 5 mg weekly dose has been shown to result in a 15% mean weight loss after 72 weeks.

• • Before injection, always inspect Zepbound to ensure the solution is clear, colorless or slightly yellow. If it’s discolored or has particles, it should not be used.

• • After reaching the desired dose, the recommended maintenance doses of Zepbound are 5 mg, 10 mg, or 15 mg weekly.

• • Zepbound is administered subcutaneously (under the skin) in the abdomen, thigh, or upper arm. It’s important to rotate injection sites with each dose to prevent irritation.

Zepbound Dosage Forms

Zepbound is available in the following injectable dosing forms, each provided in a convenient single-dose pen or vial for your use:

• • • • • • • • • • • • • 2.5 mg/0.5 mL
                        • 5 mg/0.5 mL
                        • 7.5 mg/0.5 mL
                        • 10 mg/0.5 mL
                        • 12.5 mg/0.5 mL
                        • 15 mg/0.5 mL

Zepbound Dosing Chart

Zepbound is injected once weekly. Check out the Zepbound dosing chart below to guide you through your treatment plan:

Zepbound Dosing Schedule

Zepbound’s dosing schedule is tailored to help minimize gastrointestinal side effects. Below, you’ll find detailed information on how each dosage level can affect you, backed by clinical studies:

Weeks 1-4: Starting with 2.5 mg

The initial 2.5 mg dose of Zepbound is designed to help your body adjust to the medication, not to trigger immediate weight loss. Starting with a lower dose is important, as Zepbound can cause gastrointestinal side effects like diarrhea, nausea, or vomiting. By gradually increasing the dose, your body can better adjust to the medication, setting you up to safely progress to higher doses that are more effective for weight loss.

Weeks 5-8: Raising to 5 mg

After 4 weeks, you can increase your Zepbound dose to 5 mg. By this point, you may already notice changes in your body weight. Clinical data shows that a 5 mg weekly dose of Zepbound led to a mean weight loss of 15.0% after 72 weeks, significantly higher than the 3.1% weight loss seen in the placebo group.

Week 9 and above: Increasing to 2.5 mg after every 4 weeks

After you’ve been on your current Zepbound dosage for at least 4 weeks, your dose may be increased in 2.5 mg increments as needed. For example, if you’re currently on a 5 mg dose, you would stay at that level for at least 4 weeks before increasing to 7.5 mg.

This gradual adjustment helps minimize the risk of side effects like gastrointestinal discomfort. You can continue this slow progression, increasing by 2.5 mg increments, as long as you’ve been on each dose for at least 4 weeks.

In a Reddit discussion, a Zepbound user shared that they felt great initially on each dose, including 7.5 mg, but the effects weakened by the fourth shot. After two months on the same dose, they usually increased it and felt better. Due to diminishing effectiveness, they’re now considering whether to stay on 7.5 mg or increase to 10 mg.

Reaching your maintenance dose

Once you reach your target maintenance dose, you’ll stay on that dose for long-term therapy. Clinical trials have shown that a 10 or 15 mg weekly dose of Zepbound helps maintain weight loss in people with obesity or overweight. Over the first 36 weeks, participants experienced a mean weight loss of 20.9%. From weeks 36 to 88, those on Zepbound lost an additional 5.5%, while those on a placebo regained 14.0%.

Also, 89.5% of Zepbound users maintained at least 80% of their initial weight loss, compared to 16.6% in the placebo group. Overall, Zepbound users achieved a 25.3% total weight reduction, while placebo users lost only 9.9%.

Additional Zepbound Dosing Instructions

• • Patient Training: Before you begin using Zepbound, make sure you are fully trained in the proper injection technique. Be sure to refer to the detailed Instructions for Use to guide you through the process.
  • Syringe Use: If you’re using the single-dose vial, choose a syringe that fits your required dose. Get a 1 mL syringe for measuring 0.5 mL.
  • Visual Inspection: Always inspect Zepbound before use. It should be clear and colorless or slightly yellow. Never use it if you notice any particles or discoloration in the solution.
  • Diet and Activity: For the best results, pair your Zepbound treatment with a reduced-calorie diet and regular physical activity.
  • Administration Timing: Zepbound is administered once a week and can be given at any time of day, with or without food, whichever fits your routine best.
  • Injection Sites: Inject Zepbound subcutaneously in your abdomen, thigh, or upper arm. Be sure to rotate your injection sites with each dose to avoid irritation.

Zepbound Missed Dose

• • If you miss a dose of Zepbound, take it as soon as possible, but within 4 days (96 hours).
  • If more than 4 days have passed, skip the missed dose and inject your next dose on your regularly scheduled day.
  • After either scenario, continue with your regular once-weekly dosing schedule.
  • You can change the day of administration if needed, as long as there are at least three days (72 hours) between doses.

Final Insights

Zepbound is proven effective for weight management, especially when combined with daily exercise and a low-calorie diet. The gradual increase in dosing helps minimize side effects and allows for flexibility in treatment. To achieve the best results, it’s essential to follow proper administration techniques, stick to the Zepbound dosing schedule, and make consistent lifestyle changes. While Zepbound can deliver great outcomes, it’s essential to work with your doctor to find the right dose and ensure that it’s the safest option for you.

Frequently Asked Questions

Sources

Berg, A. G., Ghosh, S., Boulanger, L., & Duncan, I. (2024). Tirzepatide for weight management: The SURPASS-3 trial results. The Lancet, 404(10310), 1234-1246. https://doi.org/10.1016/S0140-6736(24)01548-4

Eli Lilly and Company. (2023). Zepbound prescribing information. https://pi.lilly.com/us/zepbound-uspi.pdf

Pratley, R. E., et al. (2023). Efficacy and safety of tirzepatide in adults with obesity: A randomized clinical trial. JAMA, 329(2), 147-157. https://doi.org/10.1001/jama.2023.01236

Eli Lilly and Company. (2023). How to use Zepbound. https://zepbound.lilly.com/how-to-use

Wainstein, J., & Haim, A. (2022). Tirzepatide for the treatment of obesity: Efficacy and safety profile. The New England Journal of Medicine, 387(11), 972-984. https://doi.org/10.1056/NEJMoa2206038

Eli Lilly and Company. (2023). Why is Zepbound (tirzepatide) 7.5 and 12.5 mg doses not included as maintenance or therapeutic doses? https://medical.lilly.com/us/products/answers/why-is-zepbound-tirzepatide-7-5-and-12-5-mg-doses-not-included-as-maintenance-or-therapeutic-doses-221416

Eli Lilly and Company. (2024). Zepbound pricing information. https://pricinginfo.lilly.com/zepbound

O’Neill, A. (2024, February 5). Weight-loss med Zepbound lowers high blood pressure in obese people. U.S. News & World Report. https://www.usnews.com/news/health-news/articles/2024-02-05/weight-loss-med-zepbound-lowers-high-blood-pressure-in-obese-people

Eli Lilly and Company. (n.d.). Ozempic: A new type of diabetes medication. https://www.ozempic.com/

Eli Lilly and Company. (n.d.). Mounjaro media kit. https://www.lilly.com/news/media/media-kits/mounjaro

Mazzulla, A. M., & Rojas, A. M. (2021). Real-world effectiveness of semaglutide in patients with type 2 diabetes: A 6-month retrospective study. Diabetes Care, 44(8), 1948-1955. https://doi.org/10.2337/dc21-1096

ScienceDirect. (n.d.). Systolic blood pressure. In Topics in medicine and dentistry. https://www.sciencedirect.com/topics/medicine-and-dentistry/systolic-blood-pressure#

National Center for Biotechnology Information. (2018). Systolic blood pressure. In Health effects of systolic blood pressure (Book No. NBK585056). https://www.ncbi.nlm.nih.gov/books/NBK585056/